Clinical Trials Directory

Trials / Completed

CompletedNCT03176329

Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients

Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients : a Prospective Randomized Crossover Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
267 (actual)
Sponsor
Hopital of Melun · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nursing is essential in critically ill patients care but with high risk of hypoxia, especially during mobilization. Full closed-loop control ventilation is well established for her safety in unselected ventilated critical care patients with different lung conditions compared to conventional ventilation. The aim of this study is to assess the ability of a full closed-loop control ventilation (Intellivent-ASV, TM) to reduce hypoxia during mobilization period in unselected ventilated patients.

Detailed description

Prospective randomized cross over study including all consecutive ventilated patient with predicted duration of ventilation \> 48 hours, inspired oxygen fraction \< 60% and without neuromuscular blocking agent. Patient were randomized to be ventilated with full closed-loop control or conventional ventilation 30 minutes before the first nursing period after inclusion. The ventilator was switched in the other mode (conventional or full closed-loop respectively), 30 minutes before the following nursing period. Between this two consecutive nursing periods, ventilation mode is choosed by the attending physician. The primary outcome was the oxygenation measured by pulse oxymetry during the nursing periods.

Conditions

Interventions

TypeNameDescription
OTHERNursing 1 : INTELLIVENT-ASV
OTHERNursing 2 : INTELLIVENT-ASV
OTHERNursing 1 : Conventional mode
OTHERNursing 2 : Conventional mode

Timeline

Start date
2016-09-19
Primary completion
2018-07-31
Completion
2018-07-31
First posted
2017-06-05
Last updated
2018-08-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03176329. Inclusion in this directory is not an endorsement.